X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 13,414 | 10,438 | 8,054 | 8,545 | 6,376 |
| Operating Income | -13,414 | -10,438 | -8,054 | -8,545 | -6,376 |
| Interest Expense | 512 | 399 | 236 | 148 | 167 |
| Other Income | 543 | -36 | -2,992 | 91 | 509 |
| Pre-tax Income | -13,383 | -10,873 | -11,282 | -8,602 | -6,034 |
| Net Income Continuous | -13,383 | -10,873 | -11,282 | -8,602 | -6,034 |
| Net Income | $-13,383 | $-10,873 | $-11,282 | $-8,602 | $-6,034 |
| EPS Basic Total Ops | -30.63 | -200.30 | -787.69 | -612.31 | -445.35 |
| EPS Basic Continuous Ops | -30.50 | -190.06 | -737.04 | -562.79 | -394.77 |
| EPS Diluted Total Ops | -30.63 | -200.30 | -787.69 | -612.31 | -445.35 |
| EPS Diluted Continuous Ops | -30.50 | -190.06 | -737.04 | -562.79 | -394.77 |
| EBITDA(a) | $-13,390 | $-10,418 | $-8,028 | $-8,519 | $-6,351 |